(Q41588199)

4 October 2017

title

Treatment with recombinant tissue plasminogen activator (r-TPA) induces neutrophil degranulation in vitro via defined pathways (English)

1 reference

4 October 2017

3

1 reference

4 October 2017

18

1 reference

4 October 2017

Alessandro Trentini

10

0 references

Federico Carbone

object named as

Federico Carbone

1

0 references

Franco Dallegri

object named as

Franco Dallegri

11

0 references

Fabienne Burger

4

object named as

Fabienne Burger

1 reference

4 October 2017

8

Ilaria Casetta

1 reference

4 October 2017

9

Silva Seraceni

1 reference

4 October 2017

17

Enrico Fainardi

1 reference

4 October 2017

15

François Mach

1 reference

4 October 2017

13

Aldo Pende

1 reference

4 October 2017

2

Nicolas Vuilleumier

1 reference

4 October 2017

14

Nathan Artom

1 reference

4 October 2017

6

Gloria Roversi

1 reference

4 October 2017

7

Carmine Tamborino

1 reference

4 October 2017

5

Katia Galan

1 reference

4 October 2017

author name string

Analina Raquel da Silva

12

1 reference

4 October 2017

Matteo Coen

16

1 reference

4 October 2017

publication date

18 December 2014

1 reference

4 October 2017

published in

Vascular Pharmacology

1 reference

4 October 2017

volume

64

1 reference

4 October 2017

page(s)

16-27

1 reference

Neutrophil function: from mechanisms to disease

4 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.007

Neutrophil granules: a library of innate immunity proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.007

Neutrophil function in inflammation and inflammatory diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.007

Systemic and intraplaque mediators of inflammation are increased in patients symptomatic for ischemic stroke.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.007

Pathophysiological role of neutrophils in acute myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.007

Matrix metalloproteinase-9 and myeloperoxidase expression: quantitative analysis by antigen immunohistochemistry in a model of transient focal cerebral ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.007

Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.007

Inflammatory cell infiltration after endothelin-1-induced cerebral ischemia: histochemical and myeloperoxidase correlation with temporal changes in brain injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.007

Antibodies to CD11b, CD68, and lectin label neutrophils rather than microglia in traumatic and ischemic brain lesions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.007

Neutrophil elastase and neurovascular injury following focal stroke and reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.007

Temporal profile of matrix metalloproteinases and their inhibitors in a human endothelial cell culture model of cerebral ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.007

Matrix metalloproteinase-9 as a marker for acute ischemic stroke: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.007

Matrix metalloproteinase 9 mRNA: an early prognostic marker for patients with acute stroke.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.007

proMetalloproteinase-10 is associated with brain damage and clinical outcome in acute ischemic stroke.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.007

Peripheral blood levels of matrix metalloproteinase-9 predict lesion volume in acute stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.007

Profiles of matrix metalloproteinases, their inhibitors, and laminin in stroke patients: influence of different therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.007

Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.007

Tissue plasminogen activator (t-PA) promotes neutrophil degranulation and MMP-9 release.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.007

Neutrophils contribute to intracerebral haemorrhages after treatment with recombinant tissue plasminogen activator following cerebral ischaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.007

Impact of the neutrophil response to granulocyte colony-stimulating factor on the risk of hemorrhage when used in combination with tissue plasminogen activator during the acute phase of experimental stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.007

Neurological complications of acute ischaemic stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.007

Intravenous thrombolysis for acute ischaemic stroke: preliminary experience with recombinant tissue plasminogen activator in the UK.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.007

CCL3 (MIP-1α) induces in vitro migration of GM-CSF-primed human neutrophils via CCR5-dependent activation of ERK 1/2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.007

Receptor activator of NF- κB ligand (RANKL) increases the release of neutrophil products associated with coronary vulnerability.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.007

Tumor necrosis factor-alpha (TNF-α) induces integrin CD11b/CD18 (Mac-1) up-regulation and migration to the CC chemokine CCL3 (MIP-1α) on human neutrophils through defined signalling pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.007

Guidelines for the Early Management of Adults With Ischemic Stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.007

An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.007

Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.007

Measurements of acute cerebral infarction: a clinical examination scale

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.007

Outcomes in mild or rapidly improving stroke not treated with intravenous recombinant tissue-type plasminogen activator: findings from Get With The Guidelines-Stroke.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.007

Interobserver agreement for the assessment of handicap in stroke patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.007

Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.007

Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.007

An acute ischemic stroke classification instrument that includes CT or MR angiography: the Boston Acute Stroke Imaging Scale

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.007

Measurements of acute cerebral infarction: lesion size by computed tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.007

Reprint of Neutrophil cell surface receptors and their intracellular signal transduction pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.007

Metalloproteinase and stroke infarct size: role for anti-inflammatory treatment?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.007

Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.007

Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.007

MMP9 variation after thrombolysis is associated with hemorrhagic transformation of lesion and death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.007

Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.007

Treatment with Evasin-3 reduces atherosclerotic vulnerability for ischemic stroke, but not brain injury in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.007

Subtractive cloning identifies tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) increased gene expression following focal stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.007

Effect of focal mild hypothermia on expression of MMP-9, TIMP-1, Tau-1 and β-APP in rats with cerebral ischaemia/reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.007

Quality improvement and tissue-type plasminogen activator for acute ischemic stroke: a Cleveland update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.007

Increase in jugular levels of polymorphonuclear neutrophil elastase in patients with acute cerebral infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.007

The expression of matrix metalloproteinase-13 is increased in vessels with blood-brain barrier impairment in a stroke-prone hypertensive model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.007

Factors influencing haemorrhagic transformation in ischaemic stroke.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.11.007

10.1016/J.VPH.2014.11.007

7 January 2021

Identifiers

DOI

1 reference

4 October 2017

1 reference